ASCO
Milestone Monday: A Win in China. A Shift in England. A Gap Nobody Named.
Three ASCO readouts, three announcements that claimed more than the data supported — and one question the conference floor has been too busy to ask.
ASCO
Three ASCO readouts, three announcements that claimed more than the data supported — and one question the conference floor has been too busy to ask.
Tuesday
For the first time in ASCO's history, China-only data occupies the plenary slot. A hazard ratio of 0.40 in pancreatic cancer. And Lilly moving the obesity ceiling above bariatric surgery. Chicago has a lot to answer for this week.